RxDoctor Payments Data

David Abrams

Ophthalmology · San Antonio, TXNPI 1881654341

Payments from drug & device makers

$4,246in general payments, 2019–2025

Across 80 payments — averaging $53.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biotissue Holdings Inc.$852
  • Glaukos Corporation$496
  • AbbVie$417
  • Alcon$405
  • NEW World Medical,inc.$349
  • Aerie Pharmaceuticals, Inc.$336
  • plus $1K from 14 others

What the payments were for

  • Food & beverage$4,246100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,246 in reported general payments places this provider in the 65th percentile of 1,355 ophthalmology providers in Texas.

See all ophthalmology providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
LumiganBimatoprost36$12,171
RhopressaNetarsudil Mesylate12$6,542
Alphagan PBrimonidine Tartrate31$6,081
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol13$3,617
Travoprost18$2,772
Latanoprost324$2,755
Brimonidine Tartrate43$1,384
Timolol Maleate84$876
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat35$697
Dorzolamide Hcl26$570

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLumigan, Alphagan P$417$18,25267 claims
Aerie Pharmaceuticals, Inc.Rhopressa$336$6,54212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,355 ophthalmology providers in Texas.

Other ophthalmology in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →